pSivida: The Small Biotech With Big News Coming
(WorldNews Health)

pSivida (NASDAQ:PSDV) recently announced the date, November 7, 2017, for its first quarter fiscal year 2018 results, along with a conference call on the same day. Current and future investors should tune in at 8:30 AM ET for the call since pSivida will be covering significant company updates. I expect these updates to show that pSivida is making major progress in three key areas that will create positive stock price appreciation. Durasert NDA for Posterior Uveitis Uveitis is the third leading cause of preventable blindness in the developed world. Durasert is pSivida`s proven miniaturized, injectable, sustained-release drug delivery system that can fight posterior uveitis. It is for small...